1. Three-Dimensional Patient-Derived In Vitro Sarcoma Models: Promising Tools for Improving Clinical Tumor Management
   Manuela Gaebler et al, 2017, Frontiers in Oncology CrossRef
2. Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells
   Tomohiro Fujiwara et al, 2016, Stem Cells International CrossRef
3. Microenvironment Signals and Mechanisms in the Regulation of Osteosarcoma
   Yu Zhang et al, 2017, Osteosarcoma - Biology, Behavior and Mechanisms CrossRef
4. Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas
   Sofía T. Menéndez et al, 2021, Journal of Clinical Medicine CrossRef
5. Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters
   Sara R. Martins-Neves et al, 2022, International Journal of Molecular Sciences CrossRef
6. Cancer Stem Cells and Chemoresistance in Ewing Sarcoma
   Rafael Pereira dos Santos et al, 2023, Current Stem Cell Research & Therapy CrossRef
7. Trk Inhibition Reduces Tumorsphere Formation and Changes Expression of Stemness Markers in SK-ES-1 Ewing Sarcoma Cells
   Rafael Pereira dos Santos et al, 2024, Revista Brasileira de Cancerologia CrossRef
8. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
   Ingrid Lilienthal et al, 2020, International Journal of Molecular Sciences CrossRef
9. Modeling the developmental origins of pediatric cancer to improve patient outcomes
   James F. Amatruda, 2021, Disease Models & Mechanisms CrossRef
10. TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway
    Maoling Zhu et al, 2022, Open Medicine CrossRef
11. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies
    Ander Abarrategi et al, 2016, Stem Cells International CrossRef